Concepedia

[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study

Jean‐Charles Nault, Marouane Boubaya, Myriam Wartski, Anthony Dohan, Stanislas Pol, Gabriel Pop, Michaël Soussan, Olivier Sutter, Charlotte Costentin, Julie Roux,

˜The œLancet. Gastroenterology & hepatology · 2025 · 10 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 7.2K citations · Full text

, , +12

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Étienne Garin, Lambros Tselikas, Boris Guiu et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 604 citations

, , +17

Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma

Maria-Angéla Castilla-Lièvre, Dominique Franco, Philippe Gervais et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 106 citations

, , +16

Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.

Yen Rung Chen, Dar Shih Hsieh, Chao Liao et al. · PubMed · 2006 · 67 citations

, , +17

MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial

Burak Görgeç, Ingrid S Hansen, Gunter Kemmerich et al. · The Lancet Oncology · 2023 · 65 citations · Full text

, , +16